drugset / Trial / NCT00820794
A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to investigate if PD 0332334 affects the pharmacokinetics of lithium by co-administering both drugs to healthy adults.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMAGABALIN | Other / unclassified | 225 mg | Oral |
| Subject | Lithium | Unknown | 300 mg | Oral |